The expression levels of complement regulatory proteins CD46, CD55, and CD59 are notably elevated in various tumors, including head and neck squamous cell carcinoma (HNSCC) (43), colon cancer, renal cancer, lung cancer (44), and breast cancer (45). This evidence concerns the gene CD46 and head and neck squamous cell carcinoma.